| Patient | Hatshepsut |
|---|---|
| Date of birth | 1978-02-10 |
| Identifiers | MRN HR-AC006-SYN; SSN (made up) 000-06-9440 |
| Document date | 2026-06-30 |
| Author | Amunet Okafor-Harrington, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Hatshepsut is a 48-year-old woman with type 2 diabetes found eleven weeks ago, periodontitis, and knee osteoarthritis, who comes for the preventive visit booked at intake. The urinary symptoms settled within two days of nitrofurantoin, and she finished the five days; the culture grew Escherichia coli sensitive to it. She is ready to step up semaglutide to 0.5 mg today. Her extraction site has healed and scaling and root planing is booked with the dental team. Her periods have been irregular for a year, with occasional night sweats that do not trouble her. She has never had a mammogram or colorectal screening, and her last cervical screening was more than five years ago. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 48 |
| Cystitis | Resolved; culture-sensitive Escherichia coli |
| Diabetes | Metformin and semaglutide 0.25 mg; stepping up to 0.5 mg today |
| Mood | PHQ-2 0 |
Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Okafor-Harrington. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, better than in the spring |
| Psychosocial | Demanding work she enjoys; trusted advisers; feels safe at home |
| Substance use | AUDIT-C 1; no drug use |
| Tobacco | Never |
| Physical activity | Walks about 100 minutes a week; knee exercises three times a week |
| Nutrition | Smaller evening meals since starting semaglutide; fewer dates and less sweet tea |
| Sleep | Seven hours; occasional night sweats |
| Safety | Wears a seat belt; no firearm at home; screen for intimate partner violence negative |
| Sexual and reproductive health | Not sexually active at present; no pregnancy plans; periods irregular for a year |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight down 3 kg since intake, as intended |
| Eyes | Negative | No change in vision; retinal photographs normal last month |
| Ears, nose, mouth, and throat | Negative | Extraction site healed; no gum pain |
| Cardiovascular | Negative | No chest pain or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Positive | Mild fullness after large meals; no vomiting, change in bowel habit or blood in the stool |
| Genitourinary | Positive | Irregular periods for a year; no urinary symptoms now |
| Musculoskeletal | Positive | Knee pain on stairs, easier with exercises and the gel; no other bone or joint pain |
| Integumentary | Negative | No rash or changing moles |
| Endocrine | Positive | Occasional night sweats; thirst and night urination gone |
| Breast | Negative | No lump, pain or nipple discharge |
| Psychiatric | Negative | Mood good; PHQ-2 0 |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 400 mg oral tablet, one tablet by mouth every six hours as needed for dental pain, with food, for up to one week | One tablet every six hours as needed, with food; no more than four a day | Oral route | 2026-04-14 to 2026-04-22 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1 g) by mouth every six hours as needed for dental pain, alternating with ibuprofen, no more than 3 g a day, for up to one week | Two tablets every six hours as needed; no more than six a day | Oral route | 2026-04-14 to 2026-04-22 | completed | S |
| Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening meal | One tablet with the evening meal for a week, then two | Oral route | 2026-04-14 | active | S |
| Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed | 4 g to each knee up to four times a day as needed | Topical route | 2026-04-14 | active | S |
| Chlorhexidine gluconate 0.12% oral rinse, 15 mL swished for 30 seconds and spat out twice daily for two weeks after the extraction | 15 mL rinse twice daily for two weeks | Oral route | 2026-04-15 to 2026-04-29 | completed | S |
| Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks) | 0.25 mg once weekly | Subcutaneous route | 2026-05-26 to 2026-06-30 | completed | S |
| Semaglutide 0.5 mg subcutaneous injection once weekly (maintenance dose for now) | 0.5 mg once weekly | Subcutaneous route | 2026-06-30 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet daily | Oral route | 2026-05-26 | active | S |
| Nitrofurantoin monohydrate/macrocrystals 100 mg capsule, one capsule by mouth twice daily with food for five days | One capsule twice daily with food for five days | Oral route | 2026-06-23 to 2026-06-28 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-30 | Body height | 160 | cm | S |
| 2026-06-30 | Body weight | 90 | kg | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 35.2 | kg/m2 | S |
| 2026-06-30 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-06-30 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-30 | Heart rate | 76 | /min | S |
| 2026-06-30 | Respiratory rate | 14 | /min | S |
| 2026-06-30 | Body temperature | 36.6 | Cel | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-30 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-06-30 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 90.0 kg, BMI 35.2; blood pressure 120/78 |
| Mouth | Extraction socket healed; gums red with calculus, as before periodontal therapy |
| Neck | Thyroid normal; no lymph nodes |
| Breasts | No masses, skin change or axillary nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Abdomen | Soft and non-tender |
| Pelvic | Speculum examination with her consent and a chaperone; normal cervix; HPV sample taken |
| Musculoskeletal | Crepitus in both knees without effusion; no bone tenderness |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspected | resolved | confirmed | R68.84 | S — Synthetic presenting concern at the index visit, superseded by the dental diagnosis the next day. It echoes the dental disease reported on the mummy identified as hers (R, after the index date), without linking to it. |
| Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extracted | resolved | confirmed | K04.7 | S — Synthetic modern diagnosis; no historical claim is made. |
| Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albumin | active | confirmed | E11.65 | S — Synthetic screening finding at intake; not linked to the disputed claim of diabetes on the mummy (R). |
| Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easily | active | confirmed | E66.812 | S — Synthetic finding at intake, recorded in person-first language. |
| Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic finding at intake; not linked to the osteoarthritis reported on the mummy (R). |
| Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier) | active | confirmed | K05.323 | S — Synthetic finding at the dental consultation. |
| Acute uncomplicated cystitis (dysuria and frequency for two days, urine dipstick positive for leukocyte esterase and nitrite, no fever or flank pain); urine culture grew Escherichia coli sensitive to nitrofurantoin; resolved | resolved | confirmed | N30.00 | S — Synthetic intercurrent illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 120/78 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Completed today | Never smoked |
| Intimate partner violence screening | Completed today | Negative |
| Breast cancer screening | Ordered | Screening mammography every two years from 40; never screened |
| Cervical cancer screening | Completed today | Primary HPV test today; last screening more than five years ago |
| Colorectal cancer screening | Ordered | Fecal immunochemical test kit given; colonoscopy if positive or if she prefers it |
| Diabetes complications | Up to date | Retinal photographs and a comprehensive foot examination last month; urine albumin normal at intake |
| Lipid screening and statin | Up to date | On atorvastatin since last month; lipids at the next review |
| Bone density testing | Not indicated | Age 48 without a risk factor; at 65 or sooner if one appears |
| HIV screening | Completed today | Once for adults 15 to 65; sent today |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults; sent today before the first vaccine dose |
| Pneumococcal vaccine | Completed today | PCV20, one dose, for diabetes |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap; no booster recorded within ten years |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 today, for an adult with diabetes under 60 |
| Influenza vaccine | Due | In the autumn |
| COVID-19 vaccine | Due | In the autumn |
| Zoster vaccine | Not indicated | Begins at 50 |
Immunizations given today: Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult with diabetes; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]
Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Cervical Cancer: Screening (2018); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026)
Follow-up: Fourteen-week review with A1c, lipids and ALT and the screening results; second hepatitis B dose at a nurse visit four weeks from today. Results of HIV and hepatitis tests by phone. Next preventive visit in one year. Next scheduled visit 2026-07-21: fourteen-week review: A1c, lipids, weight, periodontal therapy, knees, and screening results. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment for any illness from which she could return to her work and her household, and would not want her life prolonged if she could no longer know the people around her. She named a health care agent, recorded in the confidential part of the chart and not named here. To be revisited yearly. [S]